SARS-CoV-2 (2019-nCoV) Nucleoprotein Protein ELISA Kit (CAT#: VCok-Wyb002)
For Research Use Only. We do not provide services or products directly for patients.
The ready-to-use detection kit SARS-CoV-2 (2019-nCoV) Nucleoprotein ELISA Kit is an enzyme-linked immunosorbent assay for the quantitative measurement of SARS-CoV-2 nucleocapsid.
Recognizes both natural and recombinant SARS-CoV-2 nucleocapsid.
96 well microplate coated with capture antibody; HRP-conjugated detection antibody; Standards; Wash buffer concentrate; Dilution buffer concentrate; Sample lysis buffer; Color reagent A; Color reagent B; Stop solution.
Quantitative solid phase sandwich ELISA.
Quantitative measurement of SARS-CoV-2 (2019-nCoV) nucleocapsid protein.
Store at 2 - 8°C
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.